EUVIMEDEUVIMED entdecken
Crossref

A Manufacturing Strategy Utilizing a Continuous-Mode Reactor toward Homogeneous PEGylated Bioconjugate Production

Yuichi Nakahara, Yuta Endo, Yutaka Matsuda, Aiichiro Nagaki, Kazutoshi Takahashi, Tomoko Kawaguchi, Keisuke Kato

Synthesis · 15.02.2024 · 56 (04) · 597-602

DOI: 10.1055/a-2077-6187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synthesis, erschienen am 15.02.2024. Verfasst von Yuichi Nakahara und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein PEGylation is a traditional bioconjugation technology that enhances the therapeutic efficacy and in vivo half-life of proteins by the formation of covalent bonds with highly activated ester group linked polyethylene glycol (PEG). However, the high reactivity of these reagents induces a random reaction with lysine residues on the protein surface, resulting in a heterogeneous mixture of PEGylated proteins. Moreover, the traditional batch-mode reaction has risks relating to scalability and aggregation. To overcome these risks of traditional batch-mode PEGylation, a manufacturing strategy utilizing structural analysis and a continuous-flow-mode reaction was examined. A solvent exposure analysis revealed the most reactive lysine of a protein, and the continuous-flow mode modified this lysine to achieve the mono-PEGylation of two different proteins within 2 seconds. This ultrarapid modification reaction can be applied to the gram-scale manufacturing of PEGylated bioconjugates without generating aggregates. A similar trend of the exposure level of protein lysine and mono-selectivity performed by continuous-flow PEGylation was observed, which indicated that this manufacturing strategy has the potential to be applied to the production of a wide variety of bioconjugates.

Zitieren

APA

Nakahara, Y., Endo, Y., Matsuda, Y., Nagaki, A., Takahashi, K., Kawaguchi, T., & Kato, K. (2024). A Manufacturing Strategy Utilizing a Continuous-Mode Reactor toward Homogeneous PEGylated Bioconjugate Production. Synthesis, 56(04), 597-602. https://doi.org/10.1055/a-2077-6187

Vancouver

Nakahara Y, Endo Y, Matsuda Y, Nagaki A, Takahashi K, Kawaguchi T, et al. A Manufacturing Strategy Utilizing a Continuous-Mode Reactor toward Homogeneous PEGylated Bioconjugate Production. Synthesis. 2024;56(04):597-602. doi:10.1055/a-2077-6187

BibTeX
@article{Nakahara2024,
  author = {Nakahara, Yuichi and Endo, Yuta and Matsuda, Yutaka and Nagaki, Aiichiro and Takahashi, Kazutoshi and Kawaguchi, Tomoko and Kato, Keisuke},
  title = {A Manufacturing Strategy Utilizing a Continuous-Mode Reactor toward Homogeneous PEGylated Bioconjugate Production},
  journal = {Synthesis},
  year = {2024},
  volume = {56},
  number = {04},
  pages = {597--602},
  doi = {10.1055/a-2077-6187}
}
Kostenlos starten →